221 related articles for article (PubMed ID: 17437768)
1. Prostate cancer--more information and more questions.
Dall'Era M; Carroll PR
J Urol; 2007 May; 177(5):1607-8. PubMed ID: 17437768
[No Abstract] [Full Text] [Related]
2. PSA and prostate cancer screening: the challenge of the new millennium.
Bjartell A
Eur Urol; 2007 Nov; 52(5):1284-6. PubMed ID: 17720305
[No Abstract] [Full Text] [Related]
3. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ
J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803
[TBL] [Abstract][Full Text] [Related]
4. Early diagnosis of prostate cancer: the continuing debate on the impact on mortality.
Höltl W; Lunglmayr G
Wien Klin Wochenschr; 2005 Jul; 117(13-14):440-1. PubMed ID: 16091868
[No Abstract] [Full Text] [Related]
5. Prostate cancer: screening and early detection.
Tariman JD
Adv Nurse Pract; 2006 Sep; 14(9):20. PubMed ID: 16972436
[No Abstract] [Full Text] [Related]
6. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.
Belpomme D; Irigaray P
J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186
[No Abstract] [Full Text] [Related]
7. Screening for prostate cancer - will we ever know?
Adolfsson J
Acta Oncol; 2010 Apr; 49(3):275-7. PubMed ID: 20397764
[No Abstract] [Full Text] [Related]
8. Prostate cancer: enthusiasm for screening.
Kaye KW
Med J Aust; 1995 May; 162(10):540-1. PubMed ID: 7539884
[No Abstract] [Full Text] [Related]
9. Application of prostate-specific antigen in prostate cancer.
Liang SL
MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
[No Abstract] [Full Text] [Related]
10. PSA screening: the bottom line.
Elhilali MM
CMAJ; 2000 Mar; 162(6):791-2. PubMed ID: 10750466
[No Abstract] [Full Text] [Related]
11. Mass screening for prostate cancer. The Swedish Council on Technology Assessment in Health Care.
Int J Cancer Suppl; 1996; 9():1-72. PubMed ID: 8982323
[No Abstract] [Full Text] [Related]
12. [The prostate specific antigen: what can we learn from the American experience?].
Zhao XJ
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833
[No Abstract] [Full Text] [Related]
13. [Elevated PSA--what to do?].
Machemer H; Rohde D
MMW Fortschr Med; 2008 Oct; 150(44):38-9. PubMed ID: 19024490
[No Abstract] [Full Text] [Related]
14. Prostate cancer: is the PSA test the answer?
Berlin B
N J Med; 1998 Mar; 95(3):53-5. PubMed ID: 16013148
[No Abstract] [Full Text] [Related]
15. Solving the overdiagnosis dilemma.
Esserman L; Thompson I
J Natl Cancer Inst; 2010 May; 102(9):582-3. PubMed ID: 20413743
[No Abstract] [Full Text] [Related]
16. [PSA based screening for prostatic cancer].
Johansen TE
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
[No Abstract] [Full Text] [Related]
17. Prostate cancer--the snowball is rolling.
Ruutu M; Salo J; Nordling S; Rannikko S
Ann Chir Gynaecol; 1999; 88(1):5-8. PubMed ID: 10230675
[No Abstract] [Full Text] [Related]
18. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed].
Bratt O; Björk T
Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615
[No Abstract] [Full Text] [Related]
19. Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker.
Hamilton RJ; Platz EA; Freedland SJ
J Natl Cancer Inst; 2009 Apr; 101(8):611-2. PubMed ID: 19351913
[No Abstract] [Full Text] [Related]
20. Screening for prostate cancer in 2007: the PSA era and its challenges are not over.
Shariat SF; Karakiewicz PI
Eur Urol; 2008 Mar; 53(3):457-60. PubMed ID: 18079050
[No Abstract] [Full Text] [Related]
[Next] [New Search]